The absence of clinically effective anti-fibrotic agents for chronic liver disease represents a critical therapeutic gap. Although the flavonoid quercetin exhibits potent experimental anti-fibrotic activity, its full integrative mechanisms-particularly those i... ...

请注册登录后继续浏览